Benfotiamine is a synthetic, fat-soluble derivative of thiamine (Vitamin B1) belonging to the class of allithiamine-related compounds. It is developed to provide a form of thiamine with different absorption and bioavailability characteristics compared with conventional water-soluble thiamine salts.
Benfotiamine is widely studied for its role in thiamine metabolism, cellular energy production and biochemical pathways associated with glucose metabolism. It is particularly relevant to pharmaceutical and nutritional research involving diabetic complications, peripheral nerve function and oxidative stress.
After absorption, Benfotiamine undergoes conversion through metabolic processes that ultimately contribute to the availability of thiamine and its active coenzyme form, thiamine diphosphate (TDP), also known as thiamine pyrophosphate (TPP). This coenzyme plays an important role in carbohydrate metabolism and energy production.
Benfotiamine is also investigated for its potential influence on biochemical pathways associated with advanced glycation end products (AGEs), oxidative stress and inflammatory signalling. These research areas have made it an important compound in studies involving metabolic health and nerve-related conditions.
Important distinction: Benfotiamine is chemically different from thiamine hydrochloride, thiamine mononitrate and other Vitamin B1 salts. Its chemical identity, CAS number and analytical specifications should be maintained separately.
Benfotiamine has the molecular formula C₁₉H₂₃N₄O₆PS, a molecular weight of approximately 466.45 g/mol, and CAS number 22457-89-2.
Its chemical structure is based on a thiamine-related molecule containing a phosphorus-containing substituent and a sulfur-containing heterocyclic system. The compound is commonly described as a lipid-soluble thiamine derivative.
Benfotiamine is also known by the chemical name S-benzoylthiamine O-monophosphate. Its structural characteristics distinguish it from conventional thiamine salts and contribute to its different physicochemical and absorption properties.
Chemical identity details:
Benfotiamine is investigated for its role in increasing thiamine availability and influencing metabolic pathways associated with glucose utilisation.
Following absorption, Benfotiamine is converted through enzymatic and metabolic processes into thiamine-related compounds. Thiamine is subsequently converted into thiamine diphosphate (TDP), the biologically active coenzyme form required by several enzymes involved in carbohydrate metabolism.
The general mechanism can be understood through the following steps:
One important research pathway involves transketolase, a thiamine-dependent enzyme in the pentose phosphate pathway. Increased transketolase activity has been proposed as one mechanism through which Benfotiamine may influence the accumulation of certain glucose-derived metabolic intermediates.
These mechanisms are subjects of scientific research and should not be interpreted as proof that Benfotiamine prevents or treats diabetic complications in every clinical setting.
Benfotiamine is used in the development of pharmaceutical and nutritional formulations associated with Vitamin B1 supplementation and thiamine-related metabolic research. Its lipid-soluble characteristics distinguish it from conventional thiamine salts and make it relevant to formulation studies involving alternative thiamine delivery systems.
Its applications and research areas include:
Benfotiamine has been investigated in clinical and experimental studies involving diabetic neuropathy and other complications associated with diabetes. However, evidence of clinical effectiveness varies by condition and study, and research findings should not be presented as a guarantee of therapeutic benefit.
Benfotiamine intended for pharmaceutical applications should be evaluated against an appropriate approved specification. Quality assessment should establish the identity, purity, strength and consistency of the API.
Important quality attributes may include:
HPLC or UPLC may be used for assay and related-substance evaluation, depending on the approved analytical method. Suitable spectroscopic methods can support identity confirmation.
Because Benfotiamine contains a phosphate group and a thioester-containing structure, analytical methods should be appropriate for the compound's chemical form and potential degradation pathways. Stability-indicating methods may be relevant when evaluating degradation during storage and processing.
Important IP grade clarification: The chemical identity of Benfotiamine is established, but I could not verify a current official Indian Pharmacopoeia monograph or numerical IP acceptance limits for this ingredient from the publicly available references reviewed. The Indian Pharmacopoeia Commission identifies IP as the official source of applicable drug standards. Therefore, the IP grade designation should be confirmed against the current official IP Online monograph or the approved product documentation before publication. Do not assume that a supplier's 98% research-grade purity is an IP assay specification.
Product documentation is important for verifying the identity, quality and traceability of Benfotiamine API.
A Certificate of Analysis (COA) should provide batch-specific test results, including identification, assay, related substances and other applicable quality attributes.
A Safety Data Sheet (SDS) provides information about potential hazards, safe handling, storage, exposure controls and emergency precautions.
Depending on the intended pharmaceutical application, supporting documentation may include:
All documentation should identify the correct Benfotiamine chemical form, CAS number 22457-89-2, molecular formula and batch-specific analytical results.
For Benfotiamine enquiries, contact Swapnroop Drugs & Pharmaceuticals with your required grade, quantity, target purity, intended application and destination market. Product availability, documentation and commercial terms must be confirmed by the sales team.
Benfotiamine is a synthetic derivative of thiamine (vitamin B1), also known as S-benzoylthiamine O-monophosphate.
The CAS Registry Number is 22457-89-2.
Its molecular formula is C19H23N4O6PS.
Its average molecular weight is approximately 466.45 g/mol.
It indicates a claim that the material meets the applicable Indian Pharmacopoeia standard. Compliance must be verified for the supplied grade.
Benfotiamine is a thiamine derivative used in certain vitamin-related products and investigated in biomedical research. Specific therapeutic claims require appropriate supporting evidence and regulatory authorization.
Purity depends on the product grade and approved specification. Buyers should review the applicable specification and batch COA.
Customers can enquire about the applicable COA, SDS, product specification and supporting technical documents, subject to availability.
Customers can contact Swapnroop Drugs & Pharmaceuticals with their required grade, quantity, intended application and documentation requirements.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0%–102.0% |
| Loss on Drying | NMT 1.5% |
| Residue on Ignition | NMT 0.20% |
| Heavy Metals | NMT 20 ppm |
| pH (1% Solution) | 5.0–7.0 |
| Individual Impurity | NMT 0.10% |
| Total Impurities | NMT 1.0% |
| Melting Point | 162–165°C |